GINA 2020: Potential Impacts, Opportunities, and Challenges for Primary Care

In 2019, it was reported that changes to asthma management in the Global Initiative for Asthma (GINA) “…might be considered most fundamental 30 years.” These refer recommendation treatment of adolescents and adults would no longer include short-acting ß2-agonist (SABA) only, but people with should receive either symptom-driven inhaled corticosteroids (ICS)-containing (mild asthma) or daily ICS-containing treatment. The reason this shift driven by concerns about risks consequences associated SABA-only treatment, need improve day-to-day symptoms prevent exacerbations emergent evidence. recommendations have subsequently been reinforced characterized GINA 2020, is reasonable say they are significant, not only terms an framework also as a approach practice. This opinion article specifically focuses on opportunities challenges implementation 2020 primary care practice recognized addressed if paradigm successfully implemented into